North America Asthma Spacers Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Aerochamber, Optichamber, Volumatic, and Inspirease) and Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and E-Commerce)

List of Tables

The asthma spacers market in North America is expected to grow from US$ 753.08 million in 2022 to US$ 1,035.10 million by 2028; it is estimated to grow at a CAGR of 5.4% from 2022 to 2028.

The rising usage of metered dose inhalers is the major factor driving the growth of the North America asthma spacers market. The extensively increasing prevalence of respiratory conditions, such as asthma and COPD, creates lucrative opportunities to adopt metered-dose inhalers. For instance, according to a study published by a group of researchers at the Department of Pulmonary and Critical Care Medicine, Mayo Clinic, in 2020, the number of asthma cases is expected to reach nearly 52.0% in the next 20 years in the US. Furthermore, according to the same study, the spending for the treatment of asthma in the US is expected to reach US$ 963 billion by 2038, which is expected to drive the uptake of metered-dose inhalers, eventually accelerating the adoption of inhalers and spacers during the forecast period.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America asthma spacers market. The North America asthma spacers market is expected to grow at a good CAGR during the forecast period.

North America Asthma Spacers Market Revenue and Forecast to 2028 (US$ Million)

North America Asthma Spacers Market Segmentation

North America asthma spacers market is segmented into product, distribution channel, and country. Based on product, the Asia Pacific asthma spacers market is segmented into aerochamber, optichamber, volumatic, and inspirease. In 2022, the aerochamber is expected to hold the largest market share and is expected to witness the highest CAGR from 2022 to 2028. Based on distribution channel, the Asia Pacific asthma spacers market is segmented into retail pharmacy, hospital pharmacy, and E-commerce. The retail pharmacy segment is expected to hold the largest share of the market in 2022. Based on country, the North America asthma spacers market is segmented into the US, Canada, and Mexico. The US held the largest market share in 2022.

Agaplastic, Cipla Inc., Koninklijke Philips N.V., Koo Medical Equipment, Laboratoire ProtecSom, Lupin, Metall Zug, Monaghan Medical Corporation, PARI GmbH, and Teleflex Incorporated are among the leading companies in the asthma spacers market in the region.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America asthma spacers market
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America asthma spacers market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the asthma spacers market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Product Code: BMIRE00025513

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 North America Asthma Spacers Market - By Product
- 1.3.2 North America Asthma Spacers Market - By Distribution Channel
- 1.3.3 North America Asthma Spacers Market - By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Asthma Spacers Market - Market Landscape

4.1 Overview
4.2 North America PEST Analysis
4.3 Experts Opinion

5. North America Asthma Spacers Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Rising Prevalence of Chronic Respiratory Conditions
- 5.1.2 Growing Awareness Regarding Benefits of Spacers
5.2 Market Restraints
- 5.2.1 High Risk of Adverse Effects due to Unlicensed Prescriptions
5.3 Market Opportunities
- 5.3.1 Uptake of Metered Dose Inhalers Rising
5.4 Future Trends
- 5.4.1 Emphasis on Patient-Centric Spacer Design
5.5 Impact Analysis

6. Asthma Spacers Market- North America Analysis

6.1 North America Asthma Spacers Market Revenue Forecast and Analysis
6.2 North America: Asthma Spacers Market - Revenue and forecast to 2028 (USD Million)

7. North America Asthma Spacers Market Revenue and Forecast To 2028 - by Product

7.1 Overview
7.2 North America Asthma Spacers Market, by Products, 2022 & 2028 (% Share)
7.3 Aerochamber
- 7.3.1 Overview
- 7.3.2 Aerochamber Revenue and Forecast to 2028 (US$ Mn)
7.4 Optichamber
- 7.4.1 Overview
- 7.4.2 Optichamber Revenue and Forecast to 2028 (US$ Mn)
7.5 Volumatic
- 7.5.1 Overview
- 7.5.2 Volumatic Revenue and Forecast to 2028 (US$ Mn)
7.6 Inspirease
- 7.6.1 Overview
- 7.6.2 Inspirease Revenue and Forecast to 2028 (US$ Mn)

8. North America Asthma Spacers Market Analysis and Forecast to 2028 - by Distribution Channel

8.1 Overview
8.2 North America Asthma Spacers Market, by Products, 2022 & 2028 (% Share)
8.3 Hospital Pharmacy
- 8.3.1 Overview
- 8.3.2 Hospital Pharmacy Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Retail Pharmacy
- 8.4.1 Overview
- 8.4.2 Retail Pharmacy Market Revenue and Forecast to 2028 (US$ Mn)
8.5 E-Commerce
- 8.5.1 Overview
- 8.5.2 E-Commerce Market Revenue and Forecast to 2028 (US$ Mn)

9. North America Asthma Spacers Market Revenue and Forecasts to 2028 - Country Analysis

9.1 North America: Asthma Spacers Market
- 9.1.1 Overview
- 9.1.2 North America: Asthma Spacers Market, by Country, 2022 & 2028 (%)
  - 9.1.2.1 United States: Asthma Spacers Market - Revenue and forecast to 2028 (USD Million)
    - 9.1.2.1.1 United States: Asthma Spacers Market - Revenue and forecast to 2028 (USD Million)
    - 9.1.2.1.2 United States: Asthma Spacers Market, by Product, 2019-2028 (USD Million)
    - 9.1.2.1.3 United States: Asthma Spacers Market, by Distribution Channel, 2019-2028 (USD Million)
  - 9.1.2.2 Canada: Asthma Spacers Market - Revenue and forecast to 2028 (USD Million)
    - 9.1.2.2.1 Canada: Asthma Spacers Market - Revenue and forecast to 2028 (USD Million)
    - 9.1.2.2.2 Canada: Asthma Spacers Market, by Product, 2019-2028 (USD Million)
    - 9.1.2.2.3 Canada: Asthma Spacers Market, by Distribution Channel, 2019-2028 (USD Million)
  - 9.1.2.3 Mexico: Asthma Spacers Market - Revenue and forecast to 2028 (USD Million)
    - 9.1.2.3.1 Mexico: Asthma Spacers Market - Revenue and forecast to 2028 (USD Million)
    - 9.1.2.3.2 Mexico: Asthma Spacers Market, by Product, 2019-2028 (USD Million)
    - 9.1.2.3.3 Mexico: Asthma Spacers Market, by Distribution Channel, 2019-2028 (USD Million)

10. Asthma Spacers Market-Industry Landscape

10.1 Overview
10.2 Growth Strategies Done by the Companies in the Market (%)
10.3 Organic Developments
- 10.3.1 Overview
10.4 Inorganic Developments
- 10.4.1 Overview

11. Company Profiles

11.1 Cipla Inc.
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 PARI GmbH
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Koninklijke Philips N.V.
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Lupin
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Laboratoire ProtecSom
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Monaghan Medical Corporation
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Koo Medical Equipment
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 Agaplastic
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
11.9 Teleflex Incorporated
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Products and Services
- 11.9.4 Financial Overview
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments
11.10 Metall Zug AG
- 11.10.1 Key Facts
- 11.10.2 Business Description
- 11.10.3 Products and Services
- 11.10.4 Financial Overview
- 11.10.5 SWOT Analysis
- 11.10.6 Key Developments

12. Appendix

12.1 About The Insight Partners
12.2 Glossary of Terms